Literature DB >> 10865865

Gene therapy for cardiovascular disease using hepatocyte growth factor.

R Morishita1, M Aoki, S Nakamura, J Higaki, Y Kaneda, T Ogihara.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10865865     DOI： 10.1111/j.1749-6632.2000.tb06340.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  2 in total

1.  Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.

Authors:  Hiroki Tojima; Satoru Kakizaki; Takashi Kosone; Norio Horiguchi; Yuichi Yamazaki; Ken Sato; Hitoshi Takagi; Masatomo Mori
Journal:  Hepatol Int       Date:  2011-08-05       Impact factor: 6.047

2.  Hepatocyte growth factor activates endothelial nitric oxide synthase by Ca(2+)- and phosphoinositide 3-kinase/Akt-dependent phosphorylation in aortic endothelial cells.

Authors:  Kennedy Makondo; Kazuhiro Kimura; Naoki Kitamura; Takanori Kitamura; Daisuke Yamaji; Bae Dong Jung; Masayuki Saito
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.